Anatomopathological aspects of malignant chemodectoma in a dog
Keywords:Chemoreceptors, dog, heart, malignant, neoplasm.
The objective of this case is to report the anatomopathological aspects of a chemodectoma in a dog diagnosed by the Laboratory of Veterinary Pathology (LVP) of the Federal University of Parana (UFPR) in Sector Palotina, Brazil. Chemodectomas are tumors located at the base of the heart, originating from aortic bodies, respiratory chemoreceptors located close to or inside the aortic arch, and/or receptors located in the carotid arteries. A 12-yearold male boxer dog, with a history of sudden death and without any previous clinical manifestations, was sent for postmortem examination at the LVP of UFPR, Sector Palotina, Brazil. Macroscopically, a firm mass was observed in the right atrium, with an irregular surface, blackened with multifocal to whitish coalescing areas, involving the pulmonary artery and aorta. When cut, it was smooth, blackened with multiple whitish areas. There was no intraluminal invasion, however, there was a stenosis of the pulmonary and aortic arteries. Microscopically, neuroendocrine neoplastic cells were seen to proliferate. They were well demarcated, highly cellular, with a comprehensive and encapsulated growth, not invading the wall of the atrium, aorta and pulmonary artery. Thus, concluding the diagnosis of malignant chemodectoma due to the presence of neoplastic emboli. Brachycephalic breeds are believed to be more susceptible to developing this type of neoplasm. Thus, chemodectomas may be asymptomatic since they are rare in their malignant form and the diagnosis is often only confirmed through necropsy followed by histopathological analysis.
How to Cite
Copyright (c) 2023 Uningá Review
This work is licensed under a Creative Commons Attribution 4.0 International License.
I declare/we declare that the text submitted here is original, of my own authorship and does not infringe any type of third party rights. The content is my/our sole responsibility. Possible research involving animals and/or human beings is in accordance with Resolution 196/96 of the National Health Council and its complements. I declare that I am/we are in possession of the written consent of patients and that the research and its procedures were timely and adequately approved by the Ethics Committee of the institution of origin. We further declare that all institutional affiliations and all sources of financial support for the work are duly informed. I certify that there is no commercial or associative interest that represents a conflict of interest related to the submitted work. If there is commercial interest, in addition to the technical and academic ones, in the publication of the article, the information will be reported during the text.